Achmea Investor Presentation

Transcription

1 Achmea Investor Presentation The leading Dutch insurance company with strong brands, multi-channel distribution strategy, well-diversified product range and conservative investment profile April 2014

2 CONTENTS Introduction Achmea overview Strategic agenda Key investment considerations Recent results Wrap-up Appendices 2

3 Introduction Achmea Overview ACHMEAOVERVIEW - strong brands, diversified products, focus on insurance Largest Dutch insurer A strong and solid insurance group with mutual roots Market leader in Dutch insurance: Property & Casualty, Income Protection, Health, Pension & Life insurance Distribution mainly through direct & banking channels and well positioned for future market developments Strong market position with power brands Interpolis, Centraal Beheer Achmea and Zilveren Kruis Achmea A+ IFSR, A- senior unsecured debt (S&P) Gross written premiums by segment 31/12/ Total: 22.2 billion 3

4 Introduction Achmea Overview COOPERATIVE IDENTITY The strength of our identity and our story We continue to build on our foundation of unity. Insurance stands for solidarity in society. We want our customers to continue to experience that we are a cooperative insurer. 4

5 Introduction Achmea Overview ACHMEA HISTORY Expansion Focus: optimization and innovation A group of Dutch mutual insurers form the Coöperatieve Vereniging Centraal Beheer Centraal Beheer and Avéro Insurance merge to AVCB Achmea acquires Interamerican Greece Achmea acquires 80% of Eureko Sigorta; Achmea and Agis merge Achmea creates InShared Achmea announced 4000 FTE reduction and 450 million cost reduction by end The history of Achmea* begins in Achlum, the Netherlands The first Dutch direct writer FBTO is founded Achmea founded out of AVCB and Zilveren Kruis Achmea merges with Interpolis; Rabobank becomes second largest shareholder Achmea acquires Oranta in Russia Achmea merges with DFZ and acquires Independer.nl Eureko acquired first international activities : Divestment operating companies Belgium, France, Poland, Romania Bulgaria * Eureko was the former name of the parent company of Achmea and its European subsidiaries. 5

6 Introduction Achmea Overview OWNERSHIP STRUCTURE - stability through two major cooperative shareholders Achmea Association 65.3% Rabobank Netherlands 29.2% Other 5.5% Preference shareholders 100% Ordinary shares 94.5% Achmea subholding 5.5% The mission of Achmea Association is to support the continuity of Achmea and to look after the collective interests of customers 6

7 Introduction Achmea Overview ACHMEA S STRONG ALLIANCE WITH RABOBANK Commercial Governance Commercial alliance through the banking channel. Approximately 98% of insurance products sold via the Rabobank channel are Achmea insurance products Exclusive distribution of Interpolis products through Rabobank branches Greenfield operation in Australia in cooperation with Rabobank started in 2013, with a possible extension to other growth markets. Focus is on non-life, mainly agricultural sector such as live stock, machinery, crop insurance etc. Rabobank has a nomination vote on the supervisory board of Achmea. Furthermore Rabobank and Achmea share two common supervisory board members Rabobank customers with Interpolis products 25% 31/12/ % Capital Rabobank has historically supported Achmea with capital, as and when necessary Private Wholesale Source: Achmea data December

8 Introduction Strategic agenda CLEAR LONG-TERM STRATEGIC CHOICES FOR DUTCH PORTFOLIO Channel Banking distribution Direct distribution Broker distribution Brand Product Group Property & Casualty Health Income Protection Pension - standardised Life - standardised Core proposition: strengthen Develop to core proposition Increase scale to core proposition Banking products Pension not standardised Life not standardised Complementary to insurance products Separate and manage internally or externally Our international strategy is based on these strategic choices 8

9 CONTENTS Introduction Key investment considerations Dominant player in major insurance market Well positioned with strong brands Robust capital and solvency position Conservative investment profile Recent results Wrap-up Appendices 9

10 Key investment considerations Dominant player in major insurance market LEADING POSITIONS IN OUR CORE MARKETS Market share per * Property & Casualty #1 Delta Lloyd a.s.r. Atradius SNS ING Other Reaal Health #1 VGZ CZ Menzis Other Income Protection #2 a.s.r. ING De Goudse Delta Lloyd Aegon Other Pensions #4 ING Aegon SNS Reaal Delta Lloyd a.s.r. Other Individual Life #2 ING SNS Reaal a.s.r. Delta Lloyd Aegon Other *Pensions based on % recurring premiums, all other segments based on % GWP Source: DNB October 2013 (Property & Casualty, Income Protection, Individual life), Achmea (Pensions, Health) 10

11 CONTENTS Introduction Key investment considerations Dominant player in major insurance market Well positioned with strong brands Robust capital and solvency position Conservative investment profile Recent results Wrap-up Appendices 11

12 Key investment considerations Well positioned with strong brands AROUND HALF OF ALL DUTCH PEOPLE ARE ACHMEA CUSTOMERS 12 12

13 Key investment considerations Well positioned with strong brands BRAND POWER Property & Casualty Health Individual life Brand loyalty Brand strength Achmea Competitor Source: Achmea brandpower research, Property & Casualty (July 2013), Health (Dec 2012), Individual Life (Dec 2012) 13

14 Key investment considerations Well positioned with strong brands HIGH CUSTOMER SATISFACTION P&C Retail P&C Wholesale* Income Protection* ZLM 8,4 Centraal Beheer Achmea 7,8 FBTO 7,8 Generali 7,8 VvAA 7,8 London 7,7 Interpolis 7,6 Allianz Aegon 7,6 Avéro Achmea 7,5 Europeesche Goudse 7,5 SNS Reaal 7,5 ASR 7,5 Nationale Nederlanden 7,4 Centraal Beheer Achmea Interpolis Avéro Achmea ASR Generali Aegon De Goudse ABN Amro 7,5 7,4 7,3 7,3 7,3 7,3 7,2 7,1 Centraal Beheer Achmea Generali De Goudse Avéro Achmea De Amersfoortse Interpolis 7,2 7,2 7,2 7,1 7,1 7,0 Ø 7,7 Health Ø 7,3 Individual Life Ø 7,1 Pensions* Avéro Achmea Interpolis IZA 7,6 7,6 7,6 FBTO Interpolis Generali Centraal Beheer Achmea 7,5 7,3 6,8 6,7 Centraal Beheer Achmea Interpolis Delta Lloyd 7,2 7,0 6,5 IZZ De Amersfoortse Univé VGZ 7,6 7,5 7,5 7,4 Nationale Nederlanden Avéro Achmea SNS Reaal Allianz Aegon 6,6 6,4 6,4 6,4 6,4 Avéro Achmea ASR Aegon Generali 6,4 6,4 6,4 6,0 Ø 7,5 Source: Verbond van Verzekeraars, Customer Satisfaction Research 2013 * Source: Verbond van Verzekeraars, Customer Satisfaction Research 2012 Ø 6,9 Ø 6,5 14

15 CONTENTS Introduction Key investment considerations Dominant player in major insurance market Well positioned with strong brands Robust capital and solvency position Conservative investment profile Recent results Wrap-up Appendices 15

16 Key investment considerations Robust capital and solvency position HIGH QUALITY OF CAPITAL AND LOW LEVERAGE Composition of equity Debt leverage 31/12/ Total: 9.7 billion 40% 30% 20% 10% 22,4% 21,1% 23,4% 0 dec-11 dec-12 dec-13 Capital structure 31/12/ Total: 11.2 billion Capital allocation 31/12/ Total: 11.2 billion 16

17 Key investment considerations Robust capital and solvency position SOLID SOLVENCY I POSITION Solvency I 17

18 Key investment considerations Robust capital and solvency position STRONG SOLVENCY POSITION COMPARED TO EUROPEAN PEERS Solvency I (IGD) at 31/12/

19 Key investment considerations Robust capital and solvency position STRONG SOLVENCY POSITION UNDER ALL REGIMES Solvency I (IGD) Solvency II* (Partial Internal Model) 31/12/ in billion 31/12/ in billion 202% 183% Available capital 7.95 Surplus 4.0 Required capital 3.95 Available Capital Free surplus 3.5 SCR level MCR level 4.2 Solvency II framework is still evolving; parameter changes (e.g. interest rate assumptions) make yearly comparison of full year run outcomes difficult Assumptions in our 2012 model are set conservative. Most recent proposals on the treatment of long-term guarantees will result in a significant increase in solvency levels for the life entities compared to the current full year run outcomes *excl. D&A: banks, IORP s, Non-EEA 19

20 Key investment considerations Robust capital and solvency position SOLVENCY II FRAMEWORK IS EVOLVING Full-year run 2012 Assumptions Full-year run 2013 Assumptions based on most recent proposals Adjustment discount rate for credit risk 35 bps 10 bps Discount rate: last liquid point 30 years 20 years Convergence period to UFR 40 years 40 years Countercyclical premium (CCP) 50 bps - Volatility adjustment - 30 bps Equity dampener +5% +5% Parameter changes give mere indication of outcomes of 2012 impact studies Based on the outcomes of the long-term guarantee assessment (LTGA) proposals have been drafted for the handling of long term guarantees in 2013, which supports finalising the Omnibus II directive in December Due to the delayed introduction of Solvency II, the Dutch government decided to implement additional regulation for Life insurers per 1 January The Theoretic Solvency Criterion (TSC) requires Dutch Life insures to test the effect of Solvency II shocks on the Solvency I balance sheet ( Solvency 1.5 ). This could have an impact on dividend payouts, if available capital is below TSC

21 Key investment considerations Robust capital and solvency position STABLE CREDIT RATING Credit rating insurance entities A+ A A- BBB+ BBB AA AA- BBB- Achmea was the only Dutch insurer not to be downgraded during the crisis Current Group S&P rating is A- with a stable outlook, the rating for our insurance entities is A+ also with a stable outlook. The ratings predominantly reflect our view of the group's strong business risk profile and very strong financial risk profile, based on its leading Dutch insurance franchise and very strong capital and earnings. The Achmea group has a strong competitive position, in our view, stemming from its leadership within the Dutch insurance market. In our opinion the group has very strong capital and earnings. S&P credit rating report May 27,

22 CONTENTS Introduction Key investment considerations Dominant player in major insurance market Well positioned with strong brands Robust capital and solvency position Conservative investment profile Recent results Wrap-up Appendices 22

23 Key investment considerations Conservative investment profile CONSERVATIVE INVESTMENT PORTFOLIO Total investment portfolio 31/12/ Total: 44.8 billion Fixed-income Deposits Derivatives Equities Alternatives Real estate 6% 4% 3% 2% 3% 82% Total government bond* exposure 20.7 billion, which is 56% of our fixed-income portfolio Shift of 2.8 billion (since 2012) from Dutch, German and French government bonds to investment-grade corporate bonds Fixed-income by type 31/12/ Total: 36.7 billion Government* Loans and mortgages Asset-backed bonds 22% 1% 1% Covered bonds Corporate bonds Convertible bonds Fixed-income funds 10% 2% 8% 56% * Including government related and government guaranteed bonds 23

24 Key investment considerations Conservative investment profile ACHMEA HAS A HIGH QUALITY (AA/AAA) INVESTMENT PORTFOLIO Achmea International peers 31/12/ /12/2012 Investments by type 7% 3% 6% 11% 2% 10% 61% Government bonds Corporate bonds Equities Loans and mortgages Property Funds Other (incl. cash) 15% 5% 6% 7% 8% 27% 32% 31/12/ /12/2012 6%1% Fixed-income by rating 14% 22% 41% 16% Compared with international peers Achmea invests more in fixed-income and less in real-estate. Achmea invests more than half of the portfolio in government bonds with a very high quality (AA or AAA) Achmea has shifted to more conservative credits or corporate bonds with high seniority and short maturities compared to opportunistic credit of competitors Source: Achmea, Insurance Collateral Survey, BNY Mellon/Insurance Risk/Ernst & Young, December

25 Key investment considerations Conservative Investment Portfolio Our investment portfolio Government bonds Total governments bonds (including government related and government guaranteed bonds) amounts to 20.7 billion Predominantly Dutch and German. Due to low interest rates on these bonds, part is shifted to conservative credits 31/12/ Total: 18.3 billion Top 5 sovereign exposure Country mln The Netherlands 10,729 Germany 3,322 France 1,797 Ireland* 568 Austria 526 * Our exposure to Greece and Ireland relates exclusively to our business activities there 25

26 CONTENTS Introduction Key investment considerations Recent results Group Segments Wrap-up Appendices 26

27 Recent results Group KEY MILESTONE IN RECENT YEARS focus: optimization and innovation Active portfolio management Merger with De Friesland Zorgverzekeraar, acquisition of Independer and the sale of Achmea Vitale Commercial position strengthened through acquisition of niche player Friesland Bank Assurantiën and Onderlinge Verzekeringen Overheid Sale of Avéro Belgium, Império France, Eureko Romania and Interamerican Bulgaria, Finance portfolio Ireland Operational improvements Strong financial position maintained Agis and Achmea Health integrated Closed life book managed in separate organizational entity Investments in strengthening commercial capabilities and cooperation with Independer.nl Increasing scale through consolidation (of De Friesland Zorgverzekeraar) Cost reduction by improved efficiencies and streamlining the organization Achmea announced 4000 FTE reduction and 450 million cost reduction by end 2016 Maintained Standard & Poor s A+ rating with a stable outlook for our insurance entities Group capital structure further strengthened with issue of 500 million subordinated notes and 750 million Senior Unsecured Notes, successful cash tender offer for 133 million percent capital securities and early redemption of 225 million percent capital securities Funding of Achmea Bank supported by placement of 1.3 billion of securities, including set up of new unsecured debt issuance programme December 2013 Solvency (IGD) stable at 202% Successful placement of Mortgage Securitisation (DMPL XI) at the end of July

28 Recent results Group : KEY PERFORMANCE TRENDS Profit Gross written premiums 20,233 Solvency ratio (IGD) Gross operating expenses 202% 2,660 28

29 Recent results Group 2013: ACHMEA POSTS NET PROFIT OF 344 MILLION KEY FIGURES (IN MLN) Net profit Profit before tax PBT from regular activities Gross written premiums 20,233 20,445 Gross operating expenses 2,660 2,787 KEY FIGURES (IN MLN) 31/12/ /12/2012 Total equity 9,702 10,483 Solvency insurance entities (IGD) S&P rating insurance entities 202% 212% A+ (stable) A+ (stable) Net profit of 344 million despite goodwill impairments of 232 million on pension services and health insurance Operational result up 4% to 536 million due to around 130 million reduction in operating expenses Written premiums stable, growth in core health and non-life insurance activities despite shrinking market Gross operating expenses down 5% due to complexity reduction, standardisation of processes and lower IT expenses. Cost reductions create room for future investments in innovation of products and processes Financial position remains strong, with a solvency ratio of 202% including effects of downgrading of France and UFR (Ultimate Forward Rate) method 29

30 Recent results Segments NON-LIFE NETHERLANDS Consistently strong operating performance results in further reduction in cost ratio Successful action on WGA (group occupational disability) portfolio to restore profitability Large losses suffered by business customers reimbursed after four serious industrial fires ( 45 million) and October and December storms ( 74 million) Profit before tax Property & Casualty Income Protection From 200 million to 265 million Gross written premiums From 3,151 million to 3,172 million Claims ratio Expense ratio 95.1% 89.5% 109.5% 139.5%

31 Recent results Segments HEALTH NETHERLANDS Structural result was stable over 2013; premiums remained unchanged despite higher healthcare expenditure Healthcare premiums for customers kept stable despite rising healthcare costs 90 million goodwill impairment following lower profit expectations Structural Profit before tax From 352 million to 321 million Of which Basic Health From 260 million to 259 million Gross written premiums From 13,120 million to 13,253 million Claims ratio Expense ratio Basic Health 99.1% 98.3% Supplementary Health 95.5% 94.5%

32 Recent results Segments PENSION & LIFE NETHERLANDS Lower written premiums due to stalling housing and mortgage markets, competition from bank saving products and lower pension indexations Result adversely affected by interest rate movements, including convergence of UFR curve and zero swap curve Gross operating expenses 15% lower due to sustained focus on efficiency; operating expenses down 3% Administration costs further reduced for separate closed life insurance portfolio, while maintaining high quality of service Profit before tax Value of New Business (VNB) New business (APE) From 383 million to 245 million From -19 million to -25 million From 140 million to 81 million 32

33 Recent results Segments INTERNATIONAL AND NON-INSURANCE ACTIVITIES International In Turkey, Eureko Sigorta underwrote biggest insurance contract ever for motorway project; gross written premiums up 1% In Greece, continuing success of Anytime contributed significantly to growth of market share Improvement of operational performance; operating expenses down by 14% Banking Netherlands Banking profit impacted by non-recurring expenses and additional loan loss provision Strong Tier 1 ratios at Achmea Bank (15.9%) and Staalbankiers (17.0%) Achmea Hypotheekbank successfully issued 800 million Senior Unsecured Notes and 781 million of Mortgage Securitisation (DMPL XI) Other Assets under Management at Syntrus Achmea increased further by 6.3 billion to 70 billion (year-end 2012: 64 billion) Impact of central cost management visible in reduction in project portfolio 33

34 CONTENTS Introduction Investment highlights Recent results Wrap-up Summary investment highlights Appendices 34

35 Wrap-up Summary investment highlights SUMMARY INVESTMENT HIGHLIGHTS Dominant player in major insurance market Largest Dutch insurer: high market shares in all segments Well positioned with strong brands Strong brands, high customer satisfaction Well diversified distribution network Robust capital and solvency position High quality of capital and low leverage Strong and stable Solvency I position of 202% (IGD) Strong and stable credit rating (during the crisis) Conservative investment profile Majority (82%) is invested in fixed-income, of which 72% is rated AA or higher Low asset risk compared to peers 35

36 CONTENTS Introduction Key investment considerations Recent results Wrap-up Appendices 36

37 Key investment considerations Robust capital and solvency position GOOD ACCES TO CAPITAL MARKETS Achmea outstanding securities Issuer Date issued Type Coupon (%) Coupon Type Maturity Currency Amt outst. (mln) Achmea BV 12/11/2013 Senior 2.5 FIXED 12/11/2019 EUR 750 Achmea BV 24/06/2005 Subordinated FLOATING Perp NC Jun 15 EUR 367 Achmea BV 01/11/2006 Subordinated FIXED Perp NC Nov 14 EUR 600 Achmea BV 16/06/2009 Senior FIXED 16/06/2014 EUR 750 Achmea BV 19/06/2013 Senior FIXED 19/06/2019 CHF 200 Achmea BV 04/04/2013 Subordinated FLOATING 04/04/2043 EUR 500 Achmea Mortgage Bank 26/02/2007 Covered FIXED 26/02/2014 EUR 1500 Achmea Mortgage Bank 22/08/2007 Covered FIXED 22/08/2017 CHF 200 Achmea Mortgage Bank 03/11/2009 GGB FIXED 03/11/2014 USD 950 Achmea Mortgage Bank 03/11/2009 GGB FLOATING 03/11/2014 USD 500 Achmea Mortgage Bank 08/11/2012 Senior FIXED 08/02/2016 EUR 500 Achmea Mortgage Bank 23/01/2013 Senior FLOATING 23/01/2015 EUR 300 Achmea Mortgage Bank 23/01/2013 Senior FIXED 23/01/2018 EUR

38 Appendices Real estate exposure REAL ESTATE EXPOSURE Total real estate portfolio amounts to 1.5 billion, of which 0.3 billion in indirect real estate Well-diversified portfolio with stakes in residential, office, retail and other real estate assets With the Dutch real estate market, and in particular the office market, under sustained pressure, we perform frequent valuations to give us a clear view of the value of our portfolio in these turbulent market conditions. Real estate portfolio 31/12/ Total: 1.5 billion Specification of direct real estate 31/12/ Total: 1.2 billion Type mln % Residential % Retail % Offices % Other 53 4% Total 1, % 38

39 Key investment considerations Robust capital and solvency position SENSITIVITIES Interest rate shocks In million ( ) Date Available capital Effect interest rate shock -1% Effect interest rate shock -0.4% Effect interest rate shock 0.4% Effect interest rate shock 1% , , Equity and property risk In million ( ) Asset class Effect -10% change of market value on total equity Effect -10% change of market value on solvency Equities -2% -5% Real estate -1% -3% 39 39

40 Appendices Development of equity H DEVELOPMENT OF EQUITY ,702 31/12/2012 Net result Dividend Purchase Revaluation FX IAS19 31/12/2013 of hybrids movements 40

41 CONSERVATIVE INVESTMENT PROFILE COMPARED TO PEERS Investments by type Fixed-income by rating Source: BNP Paribas Insurance Review

42 CONTACT DETAILS For further information, please contact Achmea Investor Relations Gül Poslu Manager Investor Relations +31 (0) Bastiaan Postma Manager Investor Relations +31 (0) Internet:

43 DISCLAIMER The information and the opinions in this presentation have been prepared by Achmea B.V. (the "Company" or Achmea") solely for use at a meeting regarding a proposed offering (the "Offering") of Notes of the Company (the "Notes"). This presentation and its contents are strictly confidential, are intended only for use by the recipient for information purposes only and may not be reproduced in any form or further distributed to any other person or published, in whole or in part, for any purpose. Failure to comply with this restriction may constitute a violation of applicable securities laws. By attending the meeting where this presentation is made, or by reading the presentation slides, you agree to be bound by the following limitations. This presentation does not constitute or form part of, and should not be construed as, an offer to sell, or the solicitation or invitation of any offer to buy or subscribe for, Notes in any jurisdiction or an inducement to enter into investment activity in any jurisdiction. No part of this presentation, nor the fact of its distribution, should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. Any purchase of the Notes in the Offering should be made solely on the basis of the Base Prospectus and Final Terms to be prepared in connection with the Offering. This presentation is the sole responsibility of the Company and has not been approved by any regulatory authority. The information contained in this presentation has not been independently verified. No representation, warranty or undertaking, expressed or implied, is or will be made by the Company, Barclays, Citibank, HSBC, Rabobank and Unicredit or any other investment bank involved with the Offering or their respective affiliates, advisors or representatives or any other person as to, and no reliance should be placed on, the truth, fairness, accuracy, completeness or correctness of the information or the opinions contained herein (and whether any information has been omitted from the presentation). Each of Barclays, Citibank, HSBC, Rabobank and Unicredit and any other investment bank involved with the Offering and, to the extent permitted by law, the Company and each of their respective directors, officers, employees, affiliates, advisors and representatives disclaims all liability whatsoever (in negligence or otherwise) for any loss however arising, directly or indirectly, from any use of this presentation or its contents or otherwise arising in connection with this presentation. To the extent available, the industry, market and competitive position data contained in this presentation come from official or third party sources. Third party industry publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of such data. Accordingly, undue reliance should not be placed on any of the industry, market or competitive position datacontainedin thispresentation. This presentation and any materials distributed in connection with this presentation are not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. The Notes have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold within the United States, or to, or for the account or benefit of, U.S. persons as defined in Regulation S under the Securities Act, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. Achmea does not intend to register any portion of the Offering in the United States or conduct a public offering of securities in the United States. The distribution of this presentation and other information in connection with the Offering in certain jurisdictions may be restricted by law and persons into whose possession this presentation or any document or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This presentation and any materials distributed in connection with this presentation include "forwardlooking statements". These statements contain the words "anticipate", will, "believe", "intend", "estimate", "expect" and words of similar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding the Company s financial position, prospects, growth, business strategy, plans and objectives of management for future operations (including statements relating to, among others, expected market growth, future market share, relations with the Company's shareholders, the impact of regulatory and other related developments, demographic changes, political and economic developments, competition, branch and/or sales network growth, funding plans, interest rates, net interest margin and other financial measures, product development, information technology and potential restructurings and reorganisations) are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors, including, without limitation, the risks and uncertainties to be set forth in the Prospectus, that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company's present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this presentation. The Company cautions you that forward-looking statements are not guarantees of future performance and that its actual financial position, prospects, growth, business strategy, plans and objectives of management for future operations may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. In addition, even if the Company's financial position, prospects, growth, business strategy, plans and objectives of management for future operations are consistent with the forward-looking statements contained in this presentation, those results or developments may not be indicative of results or developments in future periods. The Company does not undertake and expressly disclaims any obligation to review or confirm or to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any events that occur or conditions or circumstances that arise after the date of this presentation. The information and opinions contained in this presentation are provided as at the date of this presentation and are subject to change without notice. This presentation is made to and is directed only at persons who (i) if in the European Economic Area, are persons who are "qualified investors" within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC) ( Qualified Investors ); and (ii) if in the United Kingdom, are (a) persons who have professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the Financial Promotion Order ) or (b) high net worth entities as defined in the Financial Promotion Order or (iii) other persons to whom it may otherwise lawfully be communicated falling within Article 49(2)(a) to (e) of the Financial Promotion Order or Article 43 of the Financial Promotion Order (all such persons in (i), (ii) and (ii) above together being referred to as relevant persons ). Any person who is not a relevant person should not act or rely on this presentation or any of its contents. Any investment or investment activity to which this presentation relates is available only to and will only be engaged in with such persons. Each of Barclays, Citibank, HSBC, Rabobank and Unicredit, and their respective affiliates are acting for the Company and no one else in connection with the matters referred to in this presentation and will not regard any other person as their respective clients in relation to such matters and will not be responsible to any other person for providing the protections afforded to their respective clients, or for providing advice in relation to such matters. 43